Patients with brain injury of any etiology are at risk for developing increased intracranial pressure. Acute intracranial hypertension is a medical emergency requiring immediate intervention to prevent permanent damage to the brain. Intracranial pressure as an absolute value is not as valuable as when one investigates other important associated variables such as cerebral perfusion pressure and contributing factors for an adequate cerebral blood flow. This manuscript reviews a number of various interventions that can be used to treat acute intracranial hypertension and optimize cerebral perfusion pressure. Management options are presented in an algorithm-format focusing on current treatment strategies and treatment goals. In addition to the efficacy, clinicians must consider significant adverse events that are associated with each therapy prior to initiating treatment. The initial step includes elevation of head of the bed and adequate sedation followed by osmotic agents such as mannitol and hypertonic saline infusion. Hypothermia and pentobarbital therapy represent more aggressive steps, and utilize different mechanisms by which the pressure is controlled, likely causing significant reduction in metabolism. Surgical intervention may precede any medical therapy in order to provide more robust response in controlling intracranial hypertension in certain cases.
INTRODUCTION
Acute intracranial hypertension (AIH) is defined as sustained intracranial pressure (ICP) greater than 20 mmHg for greater than five to ten minutes in a patient that is not being stimulated. [1] [2] [3] Many disease processes can result in AIH including traumatic brain injury (TBI), large acute ischemic stroke, and intracerebral hemorrhage. The common denominator in all of these disease processes is the expansion in intracranial volume. 3 Regardless of the cause, AIH is associated with worse outcomes. 4 AIH is a medical emergency that requires rapid diagnosis and treatment to avoid irreversible damage to the brain. Multiple studies have
shown improved outcomes and reduced mortality with aggressive treatment of AIH. [5] [6] [7] In this review, pathophysiology of ICP, modalities used to monitor ICP, treatment strategies for patients with AIH, and the therapeutic goals of those treatment strategies are discussed in detail.
PATHOPHYSIOLOGY Intracranial compliance
The Monro-Kellie doctrine states that the intracranial 대한신경집중치료학회 대한신경집중치료학회 대한신경집중치료학회 space is a fixed volume inside the skull. 3 This intracranial space has three components: brain tissue, blood, and cerebrospinal fluid (CSF). In an average adult, the brain tissue volume is 1,400 mL; the blood volume is 150 mL; and the CSF volume is 150 mL. 3 Normal ICP ranges 3-15 mmHg; in the intensive care unit (ICU), ICP values less than 20 mmHg are generally accepted. Pathologic states within the intracranial vault result in an increase of volume. This is a result of at least one of the following: 1) extrinsic mass lesion, 2) increase in blood volume, 3) increase in CSF volume, or 4) increase in brain tissue. To maintain normal ICP in these pathologic states, there is a reduction in the volume of other compartments as a compensatory mechanism. As this compensatory mechanism reaches its limit, the compliance (delta V/delta P) drastically. As compliance decreases, there is a greater the change in pressure for a given change in volume (i.e., there are dramatic changes in pressure for small incremental changes in volume; Fig. 1 ). This is reflected in the ICP waveform as seen in Fig. 2 .
Cerebral perfusion pressure (CPP) is defined as mean arterial pressure (MAP) minus intracranial pressure (i.e., CPP=MAP-ICP). Therefore as ICP rises, CPP will fall. Normal CPP is 60-150 mm Hg. 8 CPP less than 60 mmHg may result in ischemic brain injury, while CPP greater than 150 mmHg can lead to hyperemia and hyperperfusion injury.
ICP MONITORING MODALITIES External ventricular drain
An external ventricular drain (EVD) is a catheter inserted into one of the lateral ventricles and connected to an external transducer via tubing filled with saline. In addition to an external transducer, there is also a fluid collection system, and a three-way stopcock allows the clinician to switch between draining fluid and transducing a pressure.
The transducer must be positioned at the level of the external auditory meatus (the level of the Foramen of Monro) to accurately measure the intracranial pressure. 3 The system can be set up to continuously drain fluid with intermittent pressure transduction or to continuously transduce a pressure with intermittent fluid drainage. The advantage of an EVD is that it is both diagnostic and therapeutic. Its major disadvantage is the risk of infection leading to meningitis or ventriculitis. Infection occurs on 10-20% of patients and this risk increases after about 5 days. 9 Some catheters are now made with antibiotic coating to help reduce infection rates, but its superiority has not been consistently shown compared to the conventional catheters. Additionally, in some ICUs, it is standard to administer systemic antibiotics during the duration of the time the catheter is in place.
In addition to acquiring actual pressure readings, it is also important to pay attention to the ICP waveforms. The second peak of the waveform either at or above the level of the first peak suggests poor brain compliance. When brain compliance is poor -even if the ICP is normal-it is not recommended to put patient's head down flat (e.g. while obtaining CT or MRI images) or wean sedation as it does not take much for ICP to rise above the acceptable level. 
TREATMENT OPTIONS FOR ACUTE INTRACRANIAL HYPERTENSION
Many treatment options exist to treat acute intracranial hypertension. The goal of these therapies is to decrease ICP to less than 20mm Hg; however, the most recent TBI guidelines from the Brain Trauma Foundation (BTF) suggest that the ICP goal should be less than 22 mmHg. 12 A step-wise algorithm is presented here which provides a standardized approach to the management of AIH. While multiple steps can be instituted as once, no step should be skipped before the initiation of a new step. Furthermore, weaning of therapies should occur in a step-wise fashion as well to avoid rebound ICP crises. Use of a stepwise algorithm in an ICU setting not only allows for wellcoordinated treatment of patients, it also can help improve outcomes. A retrospective study suggests that TBI patients in whom ICP was treated with using a standardized algorithm had fewer interventions and shorter duration of treatment compared to patients treated ad hoc. 3, 13 Prior to proceeding through the algorithm, a set of general measures should be considered. These include elevation of the head of bed to 30°, position of the head in a midline position, initiation of seizure prophylaxis, volume resuscitation, avoidance of hyperglycemia and hyperthermia.
Step 1. Surgical decompression Step 2. Sedation mmHg, systemic blood pressure should be carefully lowered using a short-acting, titratable agent (e.g., labetalol or nicardipine). It is important not to decrease the CPP so much that the intracerebral arterioles dilate resulting in reflex increased ICP as discussed in the previous paragraph.
As such, generally nitroprusside is not used to treat systemic hypertension in patients with increased ICP due to the concern for direct intracerebral vasodilation and subsequent ICP elevation. Over the next 1-3 hours however, the effect diminishes as the buffering capacity of the CSF compensates. 3, 32 Therefore, hyperventilation should only be used transiently as a temporizing measure while alternative treatments are being explored. Furthermore, it is postulated that severe hyperventilation (PaCO 2 <25 mmHg) leads to cerebral ischemia due to extreme vasoconstriction of the intracerebral arterioles. One study evaluating TBI patient observed poorer outcomes in patients prophylactically hyperventilated to PaCO 2 of 20 mmHg compared to patients ventilated normally. 33 Prolonged, prophylactic, and/or profound hyperventilation are discouraged. 8, 12 So while harmful with prolonged use, hyperventilation is life saving in patients with acutely elevated ICP as a temporary therapy. 34 Hyperventilation, although it is listed as "step number 4", it could be simultaneously initiated as steps 1 through 3 are all being instituted.
Step 5. Osmotherapy
After surgical intervention, adequate sedation and hyperventilation step fail to control ICP and optimize CPP, the next immediate step would be to initiate osmotherapy.
IV mannitol 1-1.5 g/kg solution infused over 30 minutes is reasonable and may repeat it every 6 hours as needed in order to achieve the target ICP parameter. The initial dose of IV mannitol-especially in the setting of ICP crisis-should not be under-dosed. It is however, not unreasonable to
give less than 1 g/kg for the subsequent mannitol doses. For those with normal renal function and euvolemic state, either option would lead to significant reduction in ICP.
Typically, mannitol should not be used for patients who are hypotensive with sinus tachycardia due to prerenal dehydration as osmotic diuresis would worsen hypotension.
Step 6. Hypothermia and targeted temperature modulation 
